- Home
- FEMY vs ANGH Comparison
FEMY vs ANGH Comparison
Compare FEMY & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- ANGH
- Stock Information
- Founded
- FEMY 2004
- ANGH 2012
- Country
- FEMY United States
- ANGH United Arab Emirates
- Employees
- FEMY N/A
- ANGH N/A
- Industry
- FEMY Medical/Dental Instruments
- ANGH Telecommunications Equipment
- Sector
- FEMY Health Care
- ANGH Consumer Discretionary
- Exchange
- FEMY Nasdaq
- ANGH Nasdaq
- Market Cap
- FEMY 29.9M
- ANGH 32.1M
- IPO Year
- FEMY 2021
- ANGH N/A
- Fundamental
- Price
- FEMY $0.84
- ANGH $0.46
- Analyst Decision
- FEMY Strong Buy
- ANGH
- Analyst Count
- FEMY 3
- ANGH 0
- Target Price
- FEMY $8.67
- ANGH N/A
- AVG Volume (30 Days)
- FEMY 158.0K
- ANGH 2.8M
- Earning Date
- FEMY 08-07-2025
- ANGH 08-05-2025
- Dividend Yield
- FEMY N/A
- ANGH N/A
- EPS Growth
- FEMY N/A
- ANGH N/A
- EPS
- FEMY N/A
- ANGH N/A
- Revenue
- FEMY $1,699,232.00
- ANGH $78,093,405.00
- Revenue This Year
- FEMY $283.83
- ANGH N/A
- Revenue Next Year
- FEMY $161.03
- ANGH N/A
- P/E Ratio
- FEMY N/A
- ANGH N/A
- Revenue Growth
- FEMY 61.97
- ANGH 88.72
- 52 Week Low
- FEMY $0.69
- ANGH $0.42
- 52 Week High
- FEMY $1.80
- ANGH $0.99
- Technical
- Relative Strength Index (RSI)
- FEMY 37.62
- ANGH 52.76
- Support Level
- FEMY $0.91
- ANGH $0.44
- Resistance Level
- FEMY $0.93
- ANGH $0.71
- Average True Range (ATR)
- FEMY 0.04
- ANGH 0.07
- MACD
- FEMY -0.01
- ANGH 0.01
- Stochastic Oscillator
- FEMY 5.12
- ANGH 38.70
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.